A drug combination targeting multiple mutant versions of cancer's "death star" protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.
Jun 6, 2022
0
541
Breast cancer and type 2 diabetes would seem to be distinctly different diseases, with commonality only in their commonality. Breast cancer is the second most diagnosed malignancy after some types of skin cancer; approximately ...
May 30, 2022
0
50
Researchers from the Suzhou Institute of Biomedical Engineering and Technology (SIBEBT) of the Chinese Academy of Sciences (CAS) have revealed the reasons for the inevitable occurrence of multidrug resistance during tumor ...
May 18, 2022
0
3
An algorithm that can speed up by years the ability to identify from among thousands of possibilities, two or more drugs that work synergistically against a problem like cancer or a viral infection has been developed by bioinformatics ...
May 12, 2022
0
41
Researcher Pilar Baldominos, who is currently pursuing her Universitat Politècnica de València Ph.D. at Harvard University's Dana-Farber Cancer Institute, has completed a study on the defense mechanisms used by some tumor ...
May 10, 2022
0
38
Inhibitors of the protein EZH2 are effective against cancers with SMARCB1 mutations such as rhabdoid tumors in children. However, these drugs are subject to treatment resistance. Scientists at St. Jude Children's Research ...
May 9, 2022
0
26
Most cancer treatments are based on using the maximum tolerated dose of a drug to kill as many cancer cells as possible. While this approach has led to patients achieving good responses to therapy, most patients develop drug ...
May 9, 2022
0
61
Researchers from The Australian National University (ANU) have discovered why malaria parasites are vulnerable to some drug therapies but resistant to others, offering scientists another piece of the puzzle in the global ...
May 6, 2022
0
79
New research in Advanced NanoBiomed Research indicates that testing an individual's blood can reveal the presence of circulating melanoma cells. Such tests may allow patients to forego invasive skin biopsies to determine ...
Apr 20, 2022
0
9
A recent study that shows manipulating and deleting a specific gene (AMN1) from yeast could provide a foundation for a new approach to combatting drug resistance when treating microbial infections or cancer. Led by Gábor ...
Apr 15, 2022
0
77
